MRL Ventures Fund (MRLV) invests in innovative therapeutics companies that are developing transformative medicines that have the potential to meaningfully improve the lives of patients. MRLV is based in Cambridge, MA and is actively seeking investment opportunities globally.
Looking for the highest quality, differentiated science that will redefine patient care
Committed to backing imaginative scientists and proven entrepreneurs
Agnostic to therapeutic area or modality
We do not ask for any product or technology rights as a condition of investment. We do not invest in medical devices, diagnostic platforms or digital health. For digital health opportunities, please visit Global Health Innovation Fund (GHI).
$250 million fund
27 financing events
>$70 million deployed
Traditional seed and early-stage company investments
Therapeutics companies—from concept to IND. Seek to invest up to $15 million per company, providing long-term, and committed capital
Lead or join a syndicate of investors and play an active role on company boards
Transparent and streamlined investment process
Over the life of the company, we will continue to provide capital and expertise. We protect the confidentiality of our current and future portfolio companies by providing a robust firewall from the rest of the corporation.
At a portfolio company’s choosing, MRLV can act as a conduit to the larger corporate organization to solicit advice / expertise.
Our team is growing and has years of accumulated experience as scientists, investors, entrepreneurs, and business development & licensing leaders in both biotechnology and pharmaceutical companies. This broad experience enables a rich engagement with portfolio companies and co-investors.
Reza Halse, Ph.D.
Christine Brennan, Ph.D.
Peter Dudek, Ph.D.
MRL Ventures Fund is actively developing a portfolio of early-stage therapeutic companies, which are focused on delivering innovative therapies to improve patient care.
MRL Ventures Fund
320 Bent Street
Cambridge, MA 02141